Search Medical Condition
Please enter condition
Please choose location

Schiedam, Netherlands Clinical Trials

A listing of Schiedam, Netherlands clinical trials actively recruiting patients volunteers.

RESULTS

Found (18) clinical trials

Diagnostic Properties of Aldosterone-Renin Ratio in Primary Aldosteronism Among Hypertensives.

Although primary aldosteronism (PA) was formerly seen as a rare cause of hypertension, this condition is now thought to be the commonest cause of secondary hypertension, with the prevalence ranging up to 10-15 % of all hypertensives. Identification of patients with PA allows for specific treatment, for instance unilateral adrenalectomy ...

Phase N/A

0.0 miles

Learn More »

RCT of Paclitaxel DEB Compared to Standard PTA in Dialysis Fistula

Prospective multicenter randomized (1:1) Investigator Sponsored Trial, in which 150 consecutive patients candidates for percutaneous intervention of haemodialysis access will be randomly assigned to one of two study arms: Treatment Arm: paclitaxel drug-eluting balloon (DEB) dilatation using the APERTO-balloon Control Arm: standard percutaneous transluminal angioplasty (PTA). The aim is to ...

Phase N/A

2.79 miles

Learn More »

Mycophenolate Mofetil in Antiretroviral Na ve Patients 2 (MAN2 Study)

*Background: During chronic HIV-1 infection the immune system is chronically hyperactivated. This hyperactivation is considered as the main cause of CD4+ T-cell loss. Furthermore, HIV replicates most efficiently in activated CD4+ T-cells. In this study we try to inhibit the activation of the immune system with mycophenolate mofetil (MMF). Previous ...

Phase

2.96 miles

Learn More »

Rectal and Oral Omeprazole Treatment of Reflux Disease in Infants.

Omeprazole is a highly effective drug for the treatment of gastroesophageal reflux disease (GERD) in infants. Infants, aged 0-12 months, require a non-standard dose of omeprazole. Due to this fact extemporaneous formulations of omeprazole are administered to these infants. The oral bioavailability of omeprazole in nonproprietary formulations may be unpredictable ...

Phase

2.96 miles

Learn More »

Topera E-FIRM Registry

Prospective and retrospective enrollment is possible.

Phase N/A

2.97 miles

Learn More »

Mucopolysaccharidosis (MPS) VI Clinical Surveillance Program (CSP)

The objectives of this program are: to further characterize the natural progression of MPS VI disease; to generate and disseminate information on the care and management of MPS VI patients to clinical and medical professionals; to provide a resource to physicians and patients by providing information for optimizing patient care ...

Phase N/A

3.0 miles

Learn More »

Treatment of Unstable Both-Bone Midshaft Forearm Fractures in Children

Children who arrive at the emergency unit with an unstable both-bone midshaft forearm fracture will be asked to join the trial. If the fracture will be unstable during reposition in the operating room, a randomization between 1 or 2 ESIN will be done. The aftertreatment will be the same for ...

Phase N/A

3.0 miles

Learn More »

Treatment of Non-Dislocated Midshaft Both-Bone Fractures

Children who arrive at the emergency unit with a non-dislocated both-bone midshaft forearm fracture will be asked to join the trial. After informed consent we will do a randomization between 6 weeks above elbow cast and 3 weeks above elbow cast in combination with 3 weeks under elbow cast. Outpatient ...

Phase N/A

3.0 miles

Learn More »

Implementation of a New Strategy to Identify HNPCC Patients

The Radboud University Nijmegen Medical Centre developed a new method to identify patients with HNPCC. This method appeared cost-effective and feasible. Using this new method 70% of the HNPCC patients will be identified as compared to less than 30% when the current method is used. However, this new method does ...

Phase N/A

3.4 miles

Learn More »

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

All Medtronic market-released leads and all market-released IPG, ICD and CRT devices are eligible to be included in this study.

Phase N/A

3.4 miles

Learn More »